communityacquir
respiratori
viral
carv
infect
long
thought
associ
advers
outcom
pulmonari
allograft
specif
risk
factor
acut
chronic
reject
latter
manifest
bronchiol
obliteran
syndrom
recent
restrict
phenotyp
restrict
allograft
syndrom
fall
umbrella
term
chronic
lung
allograft
dysfunct
clad
late
relationship
acut
reject
question
weight
evid
support
dissoci
acut
reject
carv
independ
risk
factor
number
specif
type
carv
consid
like
associ
develop
clad
paramyxovirus
particular
parainfluenza
seem
caus
signific
acut
loss
allograft
function
often
recov
may
progress
quit
rapidli
highgrad
bronchiol
obliteran
therapeut
intervent
limit
studi
show
benefit
treat
howev
evid
suggest
efficaci
inhal
intraven
oral
ribavirin
well
novel
trial
agent
respiratori
syncyti
viru
similar
respons
human
know
carv
key
risk
factor
poor
outcom
lung
transplant
galvan
interest
accur
diagnost
precis
identifi
caus
viral
agent
especi
symptomat
lung
transplant
recipi
lowerrespiratori
tract
infect
includ
pneumonia
link
higher
risk
develop
carv
exhibit
lowerrespiratori
tract
tropism
howev
make
biolog
sens
high
viral
load
associ
local
increas
sever
airway
epitheli
damag
defect
repair
may
lead
airflow
furthermor
studi
publish
issu
transplant
direct
magnusson
et
demonstr
persist
viral
detect
minimum
week
patient
viral
posit
author
mention
difficult
ascertain
whether
strain
viru
reinfect
new
strain
howev
extend
time
viral
clearanc
popul
may
associ
greater
period
airway
damag
due
viral
immunerel
mechan
subanalys
subject
viral
persist
regard
time
clad
develop
graft
loss
may
provid
import
insight
furthermor
incorpor
analys
viral
load
upper
lowerrespiratori
tract
sampl
subject
viral
respiratori
tract
infect
studi
may
use
determin
viralrel
factor
predispos
clad
develop
current
magnusson
et
al
articl
therefor
add
bodi
literatur
describ
carv
risk
factor
clad
term
use
author
titl
chronic
reject
absenc
demonstr
immunopatholog
pathway
probabl
accur
describ
outcom
name
clad
constru
synonym
chronic
convers
chronic
reject
like
key
contributor
semant
asid
author
show
convinc
evid
earli
carv
within
first
postop
year
associ
clad
strength
approach
includ
intens
followup
first
year
use
timedepend
multivari
cox
proport
hazard
analysi
demonstr
independ
risk
factor
acut
reject
util
cyclosporin
calcineurin
inhibitor
limit
includ
rel
small
number
enrol
subject
n
half
experienc
graft
loss
studi
potenti
bia
introduc
intens
sampl
within
first
postop
year
rather
throughout
studi
although
reflect
realworld
practic
also
effect
size
modest
hazard
ratio
p
nasopharyng
swab
perform
train
staff
critic
import
factor
acquir
repres
sampl
examin
along
bronchoalveolar
lavag
fluid
use
inhous
multiplex
polymeras
chain
reaction
broad
rang
carv
well
chlamydophila
mycoplasma
frequent
virus
detect
human
rhinoviru
coronaviru
speci
speci
test
found
bronchoalveolar
lavag
sampl
attest
lowerrespiratori
tract
involv
coronavirus
otherwis
healthi
adult
may
associ
divers
health
effect
rang
seemingli
trivial
upperairway
symptom
mild
rhinorrhoea
fatal
pneumonia
illustr
sever
acut
respiratori
syndrom
epidem
respiratori
diseas
zoonot
origin
caus
sever
acut
respiratori
syndrom
coronaviru
lung
transplant
recipi
coronavirus
associ
acut
febril
ill
variabl
persist
sever
month
individu
even
acut
ill
appear
resolv
make
interpret
concurr
infect
anoth
viru
difficult
interpret
novel
find
studi
clear
timedepend
associ
coronavirus
develop
clad
hazard
ratio
p
find
report
previous
given
larg
number
studi
report
area
tempt
ask
miss
associ
matter
see
analyz
see
altern
region
idiosyncrasi
examin
prior
studi
depth
provid
certain
insight
complet
answer
broad
rang
diagnost
tool
use
differ
oper
multiplex
polymeras
chain
reaction
employ
author
test
raft
virus
previou
tool
examin
coronavirus
detect
frequenc
low
perhap
answer
lie
somewher
name
use
sensit
tool
reflect
region
irrespect
import
addit
knowledg
worthi
studi
interest
perhap
reflect
immunomodulatori
effect
mainten
immun
suppress
author
found
major
carv
infect
asymptomat
limit
literatur
regard
presenc
asymptomat
viral
carriag
transplant
popul
howev
screen
studi
one
monitor
viral
presenc
absenc
symptom
serv
highlight
unawar
reason
high
rate
asymptomat
viral
carriag
advent
next
gener
sequenc
rang
respiratori
virus
detect
lowerrespiratori
tract
lung
transplant
patient
absenc
lead
mani
question
regard
impact
viral
presenc
clinic
outcom
remain
import
examin
find
futur
prospect
studi
transient
popul
human
respiratori
virom
carv
appear
infrequ
possibl
import
constitu
especi
immunosuppress
host
whether
carv
caus
dysbiosi
whether
becom
resid
speci
along
anellovirus
remain
elucid
tool
